LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 4 of 15: Mean cell count and mean growth rate across biological replicate 1. - Dataset (ID:20240)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | GSK1904529A | 0.04 | uM | LJP6 | 72 | hr | 513 | 3073 | 10401 | 0.2955 | 0.2589 |
MDA-MB-231 | R406 | 0.04 | uM | LJP6 | 72 | hr | 868 | 3428 | 3486 | 0.9834 | 0.9778 |
BT-20 | LDN-193189 | 0.04 | uM | LJP5 | 72 | hr | 1657 | 5401 | 5505 | 0.9811 | 0.9730 |
MCF 10A | GW843682X | 0.04 | uM | LJP6 | 72 | hr | 513 | 9055 | 10401 | 0.8706 | 0.8639 |
MDA-MB-231 | Geldanamycin | 0.04 | uM | LJP6 | 72 | hr | 868 | 1639 | 3486 | 0.4703 | 0.2947 |
MDA-MB-231 | GSK1059615 | 0.04 | uM | LJP5 | 72 | hr | 868 | 3825 | 3486 | 1.0972 | 1.1294 |
MCF 10A | HG-5-88-01 | 0.04 | uM | LJP6 | 72 | hr | 513 | 7496 | 10401 | 0.7207 | 0.7062 |
MDA-MB-231 | Omipalisib | 0.04 | uM | LJP6 | 72 | hr | 868 | 2095 | 3486 | 0.6011 | 0.4688 |
MCF 10A | HG-5-113-01 | 0.04 | uM | LJP5 | 72 | hr | 513 | 9757 | 10401 | 0.9381 | 0.9349 |
MDA-MB-231 | GW843682X | 0.04 | uM | LJP6 | 72 | hr | 868 | 2934 | 3486 | 0.8417 | 0.7892 |
BT-20 | Linifanib | 0.04 | uM | LJP6 | 72 | hr | 1657 | 5888 | 5505 | 1.0694 | 1.0994 |
BT-20 | Sigma A6730 | 0.04 | uM | LJP5 | 72 | hr | 1657 | 4910 | 5505 | 0.8918 | 0.8452 |
BT-20 | SB590885 | 0.04 | uM | LJP5 | 72 | hr | 1657 | 5376 | 5505 | 0.9765 | 0.9663 |
Hs 578T | Mitoxantrone | 0.04 | uM | LJP6 | 72 | hr | 929 | 1329 | 3228 | 0.4117 | 0.1739 |
BT-20 | Celastrol | 0.04 | uM | LJP6 | 72 | hr | 1657 | 5828 | 5505 | 1.0587 | 1.0839 |
Hs 578T | Mitoxantrone | 0.04 | uM | LJP5 | 72 | hr | 929 | 1292 | 3228 | 0.4003 | 0.1580 |
Hs 578T | PD0325901 | 0.04 | uM | LJP6 | 72 | hr | 929 | 1786 | 3228 | 0.5534 | 0.3728 |
Hs 578T | Linsitinib | 0.04 | uM | LJP5 | 72 | hr | 929 | 3174 | 3228 | 0.9834 | 0.9766 |
BT-20 | Linsitinib | 0.04 | uM | LJP5 | 72 | hr | 1657 | 4776 | 5505 | 0.8676 | 0.8106 |
Hs 578T | Nilotinib | 0.04 | uM | LJP5 | 72 | hr | 929 | 3632 | 3228 | 1.1253 | 1.1760 |
BT-20 | AT-7519 | 0.04 | uM | LJP6 | 72 | hr | 1657 | 5115 | 5505 | 0.9291 | 0.8986 |
Hs 578T | MK2206 | 0.04 | uM | LJP6 | 72 | hr | 929 | 2927 | 3228 | 0.9067 | 0.8690 |
BT-20 | AZD8055 | 0.04 | uM | LJP6 | 72 | hr | 1657 | 2584 | 5505 | 0.4695 | 0.2409 |
MDA-MB-231 | Linsitinib | 0.04 | uM | LJP5 | 72 | hr | 868 | 2600 | 3486 | 0.7460 | 0.6617 |
MDA-MB-231 | Linifanib | 0.04 | uM | LJP6 | 72 | hr | 868 | 3905 | 3486 | 1.1201 | 1.1599 |